Dr. MD Shahjalal | cancer epidemiology | Young Researcher Award

Published on by Research Scientist

Dr. MD. Shahjalal | cancer epidemiology |Young Researcher Award

Dr. MD Shahjalal, North South University , Bangladesh

Md. Shahjalal is an accomplished public health researcher from Bangladesh 🇧🇩 with a strong academic and research background in cancer epidemiology 🎗️ and global health 🌍. He holds an MPH in Epidemiology from North South University 🎓 and a BUMS from the University of Dhaka 🏥. Currently serving as Research Coordinator at Research Rats, he has contributed to numerous international publications 📚, focusing on healthcare economics and cancer care. He is also an academic editor for PLoS ONE 🖋️ and recipient of national health research grants 🏅. His work aims to reduce disparities in cancer outcomes and improve population health 💡.

Professional Profile

ORCID

Education & Experience 

Md. Shahjalal earned his Master of Public Health (MPH) in Epidemiology 🧠 from North South University (2018–2019) and Bachelor of Unani Medicine & Surgery (BUMS) 🩺 from the University of Dhaka (2012–2017). His research journey includes roles as Research Assistant (2019–2020), Research Associate (2021–2022), and currently as Research Coordinator at Research Rats Bangladesh (2023–Present) 🔬. He also worked as a Teaching Assistant in Biostatistics at NSU 📊. Through these roles, he has developed expertise in grant writing, data analysis, and multi-disciplinary research coordination 🤝, contributing to impactful studies in cancer and public health.

Professional Development 

Shahjalal’s professional growth is rooted in continuous learning and hands-on research 📈. From coordinating multi-site cancer studies to assisting in international grant applications 💼, he has gained advanced skills in public health research, data modeling, and scientific writing 📄. His expertise spans SPSS, STATA, and EXCEL for complex analyses 📊. As an academic editor for PLoS ONE 🧑‍⚖️, he stays engaged with global research trends. His participation in peer-reviewed publications and collaborative projects reflects his commitment to evidence-based solutions in healthcare. With strong communication and leadership skills 💬, he thrives in multidisciplinary teams and policy-relevant research environments 🌐.

Research Focus 

Md. Shahjalal’s research primarily targets cancer epidemiology 🎗️, health-related quality of life, and health economics 💰. His work evaluates systemic and radiation therapy outcomes, mental health disparities 🧠, and economic burdens faced by cancer survivors in Bangladesh. He also explores nutritional issues among vulnerable populations 🥣 and investigates access disparities in cardio-oncology care ❤️. Utilizing statistical modeling and health metrics like EQ-5D-5L, he aims to inform policies for equitable healthcare access 🏥. His contributions support both national and international cancer care reforms 🌍, ensuring that scientific insights lead to real-world impact for underserved communities 📢.

Awards & Honors 

Md. Shahjalal has been recognized for his impactful research through competitive grants and editorial roles 🏆. He received the Bangladesh Health Research Grant (2024) as Principal Investigator for a TB-related nutrition project 🧪 and the General Pharmaceutical Health Research Grant (2023) as Co-Investigator on cardio-oncology care disparities ❤️. With an H-index of 8 on Scopus 📈, his scholarly influence is growing steadily. He serves as an Academic Editor for PLoS ONE 🖋️, a Scopus Q1 journal, reflecting peer recognition of his academic contributions. These honors mark him as a rising leader in public health and medical research 🌟.

Publication Top Notes

1.🎯 Radioimmunotherapy in Cancer Treatment

Title: Assessing the Clinical Effectiveness of Radioimmunotherapy with Combined Radionuclide/Monoclonal Antibody Conjugates in Cancer Treatment: Insights from Randomised Clinical Trials
Journal: Cancers (2025-04-23)
DOI: 10.3390/cancers17091413
➤ Examines advanced radioimmunotherapy effectiveness using combined agents in cancer trials.

2.💰 Cancer Treatment Costs in Bangladesh

Title: Cancer Driven Direct Medical Costs in Bangladesh: Evidence from Patient Perspective
Journal: Journal of Cancer Policy (2025-03)
DOI: 10.1016/j.jcpo.2025.100565
➤ Highlights patient-incurred medical costs and economic stress related to cancer care.

3.🏥 Unplanned Hospitalisation After Cancer Therapy

Title: Emerging Burden of Post-Cancer Therapy Complications on Unplanned Hospitalisation and Costs Among Australian Cancer Patients: A Retrospective Cohort Study Over 14 Years
Journal: Scientific Reports (2025-02-08)
DOI: 10.1038/s41598-025-89247-y
➤ Evaluates long-term health complications and hospital costs post cancer therapy in Australia.

4.🥗 Diet and Dyslipidemia in Type 2 Diabetes

Title: Association between Mediterranean Diet Adherence and Dyslipidemia Among Type-2 Diabetes Mellitus Patients in Dhaka, Bangladesh
Journal: Discover Public Health (2024-10-22)
DOI: 10.1186/s12982-024-00267-x
➤ Investigates the dietary impact on lipid profiles in diabetic patients.5.

5.💸 Economic Burden on Cancer Survivors

Title: Economic Burden of Healthcare Services on Cancer Survivors in Bangladesh
Journal: Cancer Reports (2024-08)
DOI: 10.1002/cnr2.2144
➤ Quantifies healthcare costs and financial strain on cancer survivors.

Conclusion

Md. Shahjalal demonstrates exceptional research potential and output in the interdisciplinary field of cancer epidemiology, public health, and health economics. His impactful publications, leadership in funded research, and commitment to health equity mark him as a leading candidate for the Best Researcher Award. His work not only contributes academically but also has tangible implications for national and global health policy.

 

 

 

 

Dr Charles Pioger | Orthopaedic Surgery | Best Researcher Award

Published on by Research Scientist

Dr Charles Pioger | Orthopaedic Surgery | Best Researcher Award

Medical Doctor at Ambroise Paré Universitary Hospital , France

Charles Pioger, born on August 13, 1991, is a French orthopedic surgeon based in Paris. With extensive training and a strong research focus, he is dedicated to advancing the field of orthopedic surgery. 📍

Profile

Scopus

Education 🎓

Charles completed his medical graduation at the University of Lyon (2009-2015) and further specialized with a Post Graduation in Orthopedic Surgery at the University of Paris (2015-2021). His PhD studies are ongoing at the University of Toulouse III, focusing on the biological aspects of orthopedic treatments.

Experience 💼

He has held various prestigious positions in orthopedic surgery, including his current role at the University Hospital of Ambroise-Paré since November 2022. His fellowship experiences include clinical and research roles in Luxembourg and expertise in sports medicine and knee surgery.

Research Interest 🔬

Charles’s research primarily focuses on sports injuries, knee reconstruction, and the risk of septic arthritis in professional athletes. His work combines clinical practice with innovative research methodologies to enhance patient outcomes. 📊

Award 🏅

He was awarded the Silver Medal with “Very Honorable Mention” for his doctoral thesis, demonstrating his commitment to excellence in research and clinical practice.

Teaching Field 📚

From 2017 to 2022, Charles taught anatomy and arthroscopy to surgical residents, fostering the next generation of orthopedic surgeons through his educational efforts. 👨‍🏫

Research Focus 🔍

His current research focuses on the risk factors associated with septic arthritis after anterior cruciate ligament reconstruction, utilizing both retrospective analyses and literature reviews to guide clinical practices.

Future Focus Contributions 🚀

Charles aims to contribute to interdisciplinary collaborations in orthopedic research, enhancing the integration of new technologies and methodologies in clinical practice to further improve patient care and surgical outcomes. 🌐

Top Noted Publications

  • Ibañez, M. et al. (2024). Nonanatomic Posteromedial Bundle Augmentation of the Posterior Cruciate Ligament after Hyperextension Trauma. Arthroscopy Techniques.
  • Pioger, C. et al. (2024). Secondary Meniscectomy Rates and Risk Factors for Failed Repair of Ramp Lesions Performed at the Time of Primary ACL Reconstruction: An Analysis of 1037 Patients From the SANTI Study Group. American Journal of Sports Medicine, 52(8), pp. 1944–1951.
  • Farinelli, L. et al. (2024). Increased Intra-Articular Internal Tibial Rotation Is Associated With Unstable Medial Meniscus Ramp Lesions in ACL-Injured Athletes: An MRI Matched-Pair Comparative Study. Arthroscopy, Sports Medicine, and Rehabilitation.
  • Siboni, R. & Pioger, C. et al. (2024). Presentation of an intraosseous suspensory fixation technique for pediatric and adult ACL reconstruction. Orthopaedics and Traumatology: Surgery and Research.
  • Siboni, R. & Pioger, C. et al. (2024). Presentation of an intra-osseous suspensory fixation technique for pediatric and adult ACL reconstruction. Revue de Chirurgie Orthopedique et Traumatologique.
  • Lutz, C. et al. (2024). Combined ACLR and lateral extra-articular tenodesis with a continuous iliotibial band autograft is a viable option in a population of athletes who participate in pivoting sports. Knee Surgery, Sports Traumatology, Arthroscopy.
  • Sonnery-Cottet, B. et al. (2024). Incidence of and Risk Factors for Arthrogenic Muscle Inhibition in Acute Anterior Cruciate Ligament Injuries: A Cross-Sectional Study and Analysis of Associated Factors From the SANTI Study Group. American Journal of Sports Medicine.

Prof Antonella Accardo | Chimica supramolecolare | Best Paper Award

Published on by Research Scientist

Prof Antonella Accardo | Chimica supramolecolare | Best Paper Award

Professore associato at Dipartimento di farmacia, Università di Napoli “Federico II” , Italy

Antonella Accardo, born on June 12, 1978, is an accomplished Italian chemist specializing in peptide derivatives for diagnostic and therapeutic applications. With over 108 scientific publications and significant contributions to nanomedicine, she currently serves as an Associate Professor at the University of Naples “Federico II.” Her work has garnered attention from Italian enterprises, leading to multiple patent applications.

Profile

google scholar

Education 🎓

Prof. Accardo earned her Ph.D. in Biotechnology Sciences in 2004, focusing on “Peptide conjugates as diagnostic tools” under the mentorship of Professor E. Benedetti. Her academic journey includes notable research visits to the Laboratoire de Chimie de coordination in Toulouse, France, and the Division of Radiochemical Chemistry at the University Hospital Basel. She also holds a Master’s degree in the development of novel anticancer drugs from the Institute IEOSCNR of Naples.

Professional Experience 💼

Prof. Accardo began her career as an Assistant Professor in Chemistry at the University of Naples “Federico II” from 2010 to 2019, and she has served as an Associate Professor since 2020. She has actively contributed to various financed projects, collaborating with multiple research centers and recently establishing a university spin-off focused on targeted drug delivery systems for cancer treatment.

Research Interests 🔬

Her research primarily focuses on synthesizing and characterizing peptide derivatives for diagnostics and therapeutics, developing supramolecular systems for drug delivery, and exploring peptide-based bioimaging tools. She has authored over 108 publications and has an h-index of 28, reflecting her significant impact in the field.

Awards

  • 2017: Italian Peptide Society Young Scientist Award.
  • 2007-2008: Fellowship from C.I.R.C.M.S.B. at the University of Naples.
  • 2005-2007: Fellowship from EMIL at CNR-IBB Institute, Naples.

Publication Top Notes : Chimica supramolecolare

  1. Tesauro, D., Accardo, A., et al. (2019). Peptide-based drug-delivery systems in biotechnological applications: recent advances and perspectives. Molecules, 24(2), 351.
  2. Accardo, A., Tesauro, D., et al. (2009). Supramolecular aggregates containing lipophilic Gd (III) complexes as contrast agents in MRI. Coordination Chemistry Reviews, 253(17-18), 2193-2213.
  3. Accardo, A., Tesauro, D., et al. (2004). Physicochemical properties of mixed micellar aggregates containing CCK peptides and Gd complexes designed as tumor specific contrast agents in MRI. Journal of the American Chemical Society, 126(10), 3097-3107.
  4. Accardo, A., Tesauro, D., Morelli, G. (2013). Peptide-based targeting strategies for simultaneous imaging and therapy with nanovectors. Polymer Journal, 45(5), 481-493.
  5. Accardo, A., Aloj, L., et al. (2014). Receptor binding peptides for target-selective delivery of nanoparticles encapsulated drugs. International Journal of Nanomedicine, 9, 1537.
  6. Diaferia, C., Morelli, G., Accardo, A. (2019). Fmoc-diphenylalanine as a suitable building block for the preparation of hybrid materials and their potential applications. Journal of Materials Chemistry B, 7(34), 5142-5155.
  7. Diaferia, C., et al. (2019). Fmoc-FF and hexapeptide-based multicomponent hydrogels as scaffold materials. Soft Matter, 15(3), 487-496.
  8. Accardo, A., Salsano, G., et al. (2012). Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent. International Journal of Nanomedicine, 7, 2007.
  9. Tarallo, R., Accardo, A., et al. (2011). Clickable Functionalization of Liposomes with the gH625 Peptide for Intracellular Drug Delivery. Chemistry–A European Journal, 17(45), 12659-12668.
  10. Accardo, A., Tesauro, D., et al. (2007). Nanostructures by self‐assembling peptide amphiphile as potential selective drug carriers. Peptide Science, 88(2), 115-121.